Overexpression of MTHFD1 in hepatocellular carcinoma predicts poorer survival and recurrence
- 18 April 2019
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (15) , 1771-1780
Abstract
Aim: MTHFD1 was the enzyme providing one-carbon derivatives of tetrahydrofolate. We sought to investigate the impact of MTHFD1 on hepatocellular carcinoma (HCC). Methods: Bioinformatic analysis, western blot and immunohistochemistry were conducted to detect MTHFD1 expression in HCC. The relationships between MTHFD1 and prognosis of 172 HCCs were analyzed by Kaplan–Meier method and Cox proportional hazards model. Results: High MTHFD1 expression in HCC represented poor prognosis (overall survival p = 0.025; time to recurrence p = 0.044). Combining MTHFD1 with serum AFP, survival analysis demonstrated the prognosis of the MTHFD1 low expression and AFP ≤20 ng/ml group was better than that of the MTHFD1 high expression or AFP >20 ng/ml group and the MTHFD1 high expression and AFP >20 ng/ml group (overall survival p < 0.0001; time to recurrence p < 0.0001). Conclusion: High MTHFD1 expression in HCC indicated poorer prognosis. Combining MTHFD1 with serum AFP improved the accuracy of prognostic prediction.Keywords
Funding Information
- National Natural Science Foundation of China (81472278, 81472769, 81201937)
- National Natural Science Foundation of China (81521091)
This publication has 31 references indexed in Scilit:
- Human mutations in methylenetetrahydrofolate dehydrogenase 1 impair nuclear de novo thymidylate biosynthesisProceedings of the National Academy of Sciences, 2014
- Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile softwareMedical Oncology, 2014
- Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular CarcinomaJournal of Immunology Research, 2014
- SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinomaJournal of Hepatology, 2013
- Carcinogênese de cabeça e pescoço: impacto do polimorfismo MTHFD1 G1958ARevista da Associação Médica Brasileira, 2011
- Mthfd1 is a modifier of chemically induced intestinal carcinogenesisCarcinogenesis, 2010
- The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defectsHuman Mutation, 2008
- Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish populationEuropean Journal of Human Genetics, 2006
- X-TileClinical Cancer Research, 2004
- Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemiaThe Pharmacogenomics Journal, 2003